إعلان
إعلان
IMMX
Immix Biopharma, Inc. Common Stock
4.87
USDبرعاية
-0.22
-4.38%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.87
0.00
+0.06%
تقارير أرباح IMMX
النسبة الإيجابية المفاجئة
IMMX تفوق 5 من 11 آخر التقديرات.
45%
التقرير التالي
بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.16
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-33.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/--
Immix Biopharma, Inc. Common Stock earnings per share and revenue
On ٠٧ نوفمبر ٢٠٢٥, IMMX reported earnings of -0.24 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -23.84% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a +2.86% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.16 USD, with revenue projected to reach -- USD, implying an نقصان of -33.33% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Immix Biopharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Immix Biopharma, Inc. Common Stock reported EPS of -$0.24, missing estimates by -23.84%, and revenue of --, -- -- expectations.
How did the market react to Immix Biopharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2.86%, changed from $3.15 before the earnings release to $3.24 the day after.
When is Immix Biopharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
What are the forecasts for Immix Biopharma, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Immix Biopharma, Inc. Common Stock is expected to report EPS of -$0.16 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان